Although decreasing in the incidence over the last years, currently gastric adenocarcinoma represents the second cause of cancer related-death worldwide. Further knowledge and novel therapies are desperately needed in order to make the prognosis of these patients more acceptable. Infact, even though in recent years numerous staging parameters have been largely studied and unanimously recognized for their clinical and prognostic value, today too many shadows still exist around the capacity to predict exactly the natural history or post-treatment behavior of this cancer even among patients of the same stage. This study has identified the presence of isolated cancer cells as well as tumor markers (CEA, Ca 19.9, Ca 72.4 and Ca 50) from the gast...
Cancer specimens obtained via surgical resection or biopsy are generally used to understand tumor-as...
Background: Gastric cancer tumor markers, such as carcinoembryonic antigen (CEA) and cancer antigen ...
Background/Aims: The serum tumor markers, such as CEA and CA19-9, for gastric cancer have been used ...
OBJECTIVES: To investigate gastric lavage (GL) cytopathology and immunometric analysis as novel clin...
OBJECTIVE: As of 2017, the pathobiology of gastric cancer (GC) is far from fully understood; conseq...
As of 2017, no serum tumor marker has shown high levels of sensitivity or specificity for early dete...
Serum tumor markers are blood-based biomarkers that are potentially useful in cancer detection, surv...
Aim: An endoscopy is mainly used to obtain an early diagnosis confirming or excluding a gastrointest...
The progress made in the last few years made available a large amount of information that needs to b...
Differently from other digestive malignancies, gastric cancer (GC) pathobiology is still little know...
Introduction/objective: Differently from other digestive malignancies, gastric cancer (GC) pathobiol...
Peritoneal metastasis is the most common pattern of recurrence and the most frequent cause of death ...
The role of tissue CEA localization as a complementary factor in prognosis of patients affected by g...
Introduction : Peritoneal tumor seeding is a common form of recurrence after gastric cancer surgery....
In order to ascertain the role of gastric carcinoembryonic antigen (CEA) determination in detecting ...
Cancer specimens obtained via surgical resection or biopsy are generally used to understand tumor-as...
Background: Gastric cancer tumor markers, such as carcinoembryonic antigen (CEA) and cancer antigen ...
Background/Aims: The serum tumor markers, such as CEA and CA19-9, for gastric cancer have been used ...
OBJECTIVES: To investigate gastric lavage (GL) cytopathology and immunometric analysis as novel clin...
OBJECTIVE: As of 2017, the pathobiology of gastric cancer (GC) is far from fully understood; conseq...
As of 2017, no serum tumor marker has shown high levels of sensitivity or specificity for early dete...
Serum tumor markers are blood-based biomarkers that are potentially useful in cancer detection, surv...
Aim: An endoscopy is mainly used to obtain an early diagnosis confirming or excluding a gastrointest...
The progress made in the last few years made available a large amount of information that needs to b...
Differently from other digestive malignancies, gastric cancer (GC) pathobiology is still little know...
Introduction/objective: Differently from other digestive malignancies, gastric cancer (GC) pathobiol...
Peritoneal metastasis is the most common pattern of recurrence and the most frequent cause of death ...
The role of tissue CEA localization as a complementary factor in prognosis of patients affected by g...
Introduction : Peritoneal tumor seeding is a common form of recurrence after gastric cancer surgery....
In order to ascertain the role of gastric carcinoembryonic antigen (CEA) determination in detecting ...
Cancer specimens obtained via surgical resection or biopsy are generally used to understand tumor-as...
Background: Gastric cancer tumor markers, such as carcinoembryonic antigen (CEA) and cancer antigen ...
Background/Aims: The serum tumor markers, such as CEA and CA19-9, for gastric cancer have been used ...